FLGT vs. SMG

Last updated Apr 2, 2026

Compare and contrast key facts about Fulgent Genetics, Inc. (FLGT) and The Scotts Miracle-Gro Company (SMG).

Performance

FLGT vs. SMG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fulgent Genetics, Inc. (FLGT) and The Scotts Miracle-Gro Company (SMG). The values are adjusted to include any dividend payments, if applicable.

FLGT vs. SMG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FLGT Fulgent Genetics, Inc.	-37.42%	42.23%	-36.11%	-2.92%	-70.39%	93.07%	303.88%	306.94%	-27.63%	-62.14%
SMG The Scotts Miracle-Gro Company	5.56%	-8.01%	8.28%	36.92%	-68.81%	-18.03%	96.18%	77.05%	-41.00%	14.46%

Fundamentals

Market Cap FLGT : $505.97M SMG : $3.53B
EPS FLGT : -$1.97 SMG : $1.55
PS Ratio FLGT : 1.57 SMG : 1.06
Total Revenue (TTM) FLGT : $322.67M SMG : $3.35B
Gross Profit (TTM) FLGT : $130.88M SMG : $1.04B
EBITDA (TTM) FLGT : -$45.71M SMG : $447.10M

Returns By Period

In the year-to-date period, FLGT achieves a -37.42% return, which is significantly lower than SMG's 5.56% return.

FLGT

• 1D: 3.40%
• 1M: 15.77%
• YTD: -37.42%
• 6M: -30.04%
• 1Y: -5.03%
• 3Y*: -19.25%
• 5Y*: -30.37%
• 10Y*: —

SMG

• 1D: 0.33%
• 1M: -13.31%
• YTD: 5.56%
• 6M: 6.84%
• 1Y: 16.38%
• 3Y*: -0.16%
• 5Y*: -21.80%
• 10Y*: 1.42%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

FLGT vs. SMG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FLGT

FLGT Risk / Return Rank: 38
FLGT Sharpe Ratio Rank: 36
FLGT Sortino Ratio Rank: 37
FLGT Omega Ratio Rank: 40
FLGT Calmar Ratio Rank: 39
FLGT Martin Ratio Rank: 38

SMG

SMG Risk / Return Rank: 53
SMG Sharpe Ratio Rank: 56
SMG Sortino Ratio Rank: 50
SMG Omega Ratio Rank: 50
SMG Calmar Ratio Rank: 56
SMG Martin Ratio Rank: 54

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FLGT vs. SMG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fulgent Genetics, Inc. (FLGT) and The Scotts Miracle-Gro Company (SMG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FLGT	SMG	Difference
Sharpe ratio Return per unit of total volatility	-0.08	0.43	-0.51
Sortino ratio Return per unit of downside risk	0.33	0.85	-0.52
Omega ratio Gain probability vs. loss probability	1.06	1.11	-0.05
Calmar ratio Return relative to maximum drawdown	-0.05	0.68	-0.73
Martin ratio Return relative to average drawdown	-0.15	1.31	-1.46
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FLGT vs. SMG - Sharpe Ratio Comparison

The current FLGT Sharpe Ratio is -0.08, which is lower than the SMG Sharpe Ratio of 0.43. The chart below compares the historical Sharpe Ratios of FLGT and SMG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	FLGT	SMG	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.08	0.43	-0.51
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.59	-0.48	-0.11
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.04	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.08	0.22	-0.13

Correlation

The correlation between FLGT and SMG is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

FLGT vs. SMG - Dividend Comparison

FLGT has not paid dividends to shareholders, while SMG's dividend yield for the trailing twelve months is around 4.33%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FLGT Fulgent Genetics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SMG The Scotts Miracle-Gro Company	4.33%	4.52%	3.98%	4.14%	5.43%	1.59%	3.72%	2.13%	3.51%	1.93%	2.03%	2.85%

Drawdowns

FLGT vs. SMG - Drawdown Comparison

The maximum FLGT drawdown since its inception was -92.50%, which is greater than SMG's maximum drawdown of -83.55%. Use the drawdown chart below to compare losses from any high point for FLGT and SMG.

Drawdown Indicators

	FLGT	SMG	Difference
Max Drawdown Largest peak-to-trough decline	-92.50%	-83.55%	-8.95%
Max Drawdown (1Y) Largest decline over 1 year	-55.30%	-23.85%	-31.45%
Max Drawdown (5Y) Largest decline over 5 years	-87.56%	-83.55%	-4.01%
Max Drawdown (10Y) Largest decline over 10 years	—	-83.55%	—
Current Drawdown Current decline from peak	-91.06%	-71.06%	-20.00%
Average Drawdown Average peak-to-trough decline	-61.04%	-20.88%	-40.16%
Ulcer Index Depth and duration of drawdowns from previous peaks	18.34%	12.27%	+6.07%

Volatility

FLGT vs. SMG - Volatility Comparison

The current volatility for Fulgent Genetics, Inc. (FLGT) is 10.83%, while The Scotts Miracle-Gro Company (SMG) has a volatility of 14.01%. This indicates that FLGT experiences smaller price fluctuations and is considered to be less risky than SMG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FLGT	SMG	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.83%	14.01%	-3.18%
Volatility (6M) Calculated over the trailing 6-month period	56.45%	22.89%	+33.56%
Volatility (1Y) Calculated over the trailing 1-year period	59.71%	38.62%	+21.09%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	51.88%	45.95%	+5.93%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	76.12%	40.05%	+36.07%

Financials

FLGT vs. SMG - Profitability Comparison

The chart below illustrates the profitability comparison between Fulgent Genetics, Inc. and The Scotts Miracle-Gro Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

FLGT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Fulgent Genetics, Inc. reported a gross profit of 32.58M and revenue of 83.34M. Therefore, the gross margin over that period was 39.1%.

SMG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, The Scotts Miracle-Gro Company reported a gross profit of 88.70M and revenue of 354.40M. Therefore, the gross margin over that period was 25.0%.

FLGT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Fulgent Genetics, Inc. reported an operating income of -6.77M and revenue of 83.34M, resulting in an operating margin of -8.1%.

SMG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, The Scotts Miracle-Gro Company reported an operating income of -21.80M and revenue of 354.40M, resulting in an operating margin of -6.2%.

FLGT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Fulgent Genetics, Inc. reported a net income of -23.42M and revenue of 83.34M, resulting in a net margin of -28.1%.

SMG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, The Scotts Miracle-Gro Company reported a net income of -125.00M and revenue of 354.40M, resulting in a net margin of -35.3%.